Search

Your search keyword '"Yonemura, Masahito"' showing total 18 results
Start Over Author "Yonemura, Masahito"
18 results on '"Yonemura, Masahito"'

1. Clinical and biomarker factors affecting survival in patients with platinum-sensitive relapsed ovarian cancer receiving olaparib monotherapy: a multicenter retrospective study

Author

Tashiro, Ryota, Kawazoe, Hitoshi, Mamishin, Kanako, Seto, Keisuke, Udagawa, Ryoko, Saito, Yoshimasa, Hashimoto, Hironobu, Shimoi, Tatsunori, Yonemori, Kan, Yonemura, Masahito, Terakado, Hiroyuki, Nishimura, Takahiro, Kawasaki, Toshikatsu, Furukawa, Tetsuya, and Nakamura, Tomonori

Published
2023
Full Text
View/download PDF

2. Current Status and Issues of Collaboration Between Physicians and Pharmacists in Fertility Preservation

Author

Maezawa, Tadashi, primary, Yonemura, Masahito, additional, Baba, Kaede, additional, Takeuchi, Hiroki, additional, Hioki, Miki, additional, Nishimura, Ayako, additional, Minatogawa, Hiroko, additional, Utano, Tomoyuki, additional, Amino, Kazuma, additional, Ito, Masami, additional, Akita, Naohiro, additional, Iwatani, Tsuguo, additional, and Suzuki, Nao, additional

Published
2024
Full Text
View/download PDF

3. Guidance on the need for contraception related to use of pharmaceuticals: the Japan Agency for Medical Research and Development Study Group for providing information on the proper use of pharmaceuticals in patients with reproductive potential

Author

Suzuki, Nao, Takai, Yasushi, Yonemura, Masahito, Negoro, Hiromitsu, Motonaga, Shinya, Fujishiro, Noriko, Nakamura, Eishin, Takae, Seido, Yoshida, Saori, Uesugi, Koji, Ohira, Takashi, Katsura, Aiko, Fujiwara, Michio, Horiguchi, Itsuko, Kosaki, Kenjiro, Onodera, Hiroshi, and Nishiyama, Hiroyuki

Published
2022
Full Text
View/download PDF

4. Patient-associated risk factors for severe anemia in patients with advanced ovarian or breast cancer receiving olaparib monotherapy: A multicenter retrospective study

Author

Tashiro, Ryota, primary, Kawazoe, Hitoshi, additional, Mamishin, Kanako, additional, Seto, Keisuke, additional, Udagawa, Ryoko, additional, Saito, Yoshimasa, additional, Hashimoto, Hironobu, additional, Shimoi, Tatsunori, additional, Yonemori, Kan, additional, Yonemura, Masahito, additional, Terakado, Hiroyuki, additional, Kawasaki, Toshikatsu, additional, Furukawa, Tetsuya, additional, and Nakamura, Tomonori, additional

Published
2022
Full Text
View/download PDF

6. Evaluation of a Webinar for Pharmacists Learning Basic Clinical-Oncology during COVID-19 Pandemic in Japan

Author

Terazono, Hideyuki, primary, Tsuchiya, Masami, additional, Maki, Yosuke, additional, Yoshikawa, Naoki, additional, Kawahara, Yosuke, additional, Nishimura, Keiko, additional, Shinohara, Keisuke, additional, Ogawa, Daisuke, additional, Mori, Riho, additional, Iwamoto, Yoshihiro, additional, Itagaki, Fumio, additional, Masuko, Hiroyuki, additional, Yonemura, Masahito, additional, and Uchida, Mayako, additional

Published
2022
Full Text
View/download PDF

7. Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial

Author

Zenda, Sadamoto, Yamaguchi, Takuhiro, Yokota, Tomoya, Miyaji, Tempei, Mashiko, Tomoe, Tanaka, Mari, Yonemura, Masahito, Takeno, Misaki, Okano, Tomoka, Kawasaki, Toshikatsu, Nakamori, Yuko, Ishii, Shinobu, Shimada, Sanae, Kanamaru, Miyuki, and Uchitomi, Yosuke

Published
2018
Full Text
View/download PDF

8. Evaluation of a web‐based educational programme for pharmacists during the COVID‐19 pandemic in Japan

Author

Tsuchiya, Masami, primary, Terazono, Hideyuki, additional, Maki, Yosuke, additional, Yoshikawa, Naoki, additional, Kawahara, Yosuke, additional, Nishimura, Keiko, additional, Shinohara, Keisuke, additional, Ogawa, Daisuke, additional, Mori, Riho, additional, Iwamoto, Yoshihiro, additional, Itagaki, Fumio, additional, Masuko, Hiroyuki, additional, Yonemura, Masahito, additional, and Uchida, Mayako, additional

Published
2021
Full Text
View/download PDF

10. A multicenter phase I/II study of TAS-102 with nintedanib in patients (pts) with metastatic colorectal cancer (mCRC) refractory to standard therapies (N-TASK FORCE): EPOC1410.

Author

Kuboki, Yasutoshi, primary, Nishina, Tomohiro, additional, Yamaguchi, Kensei, additional, Shinozaki, Eiji, additional, Komatsu, Yoshito, additional, Yuki, Satoshi, additional, Yamazaki, Kentaro, additional, Hara, Hiroki, additional, Fukutani, Miki, additional, Uchida, Yasue, additional, Tsukahara, Natsuko, additional, Hasegawa, Hiromi, additional, Matsuda, Seiko, additional, Okamoto, Wataru, additional, Yonemura, Masahito, additional, Nomura, Shogo, additional, Sato, Akihiro, additional, Ohtsu, Atsushi, additional, and Yoshino, Takayuki, additional

Published
2016
Full Text
View/download PDF

13. Stability of Oxaliplatin Injection in FOLFOX Regimen

Author

Otsuka, Tomonobu, primary, Suzuki, Mieko, additional, Kato, Yasuhisa, additional, Hashimoto, Hironobu, additional, Yonemura, Masahito, additional, Makino, Yoshinori, additional, Higuchi, Junichi, additional, Hojo, Taisuke, additional, and Shimada, Yasuhiro, additional

Published
2006
Full Text
View/download PDF

17. [International Comparison of Clinical Information Related to Contraception of Medicines].

Author

Yonemura M, Fujishiro N, and Motonaga S

Subjects
Europe, Female, Humans, Japan, Male, Time Factors, United States, Contraception, Pharmaceutical Preparations
Abstract

Most of the warnings about the contraceptive period when using medicines are described as"fixed period"in the package insert, and it is necessary for healthcare professionals to provide information on the specific contraceptive period when using medicines that require contraception. There are many situations where we have trouble. Furthermore, the presence or absence of a description that requires contraception and the contraceptive period differ even though the drugs are the same in Japan and overseas. For example, paclitaxel injection(albumin suspension type)in the package insert in Japan, an appropriate contraceptive period for a certain period have been given to female and male are required. In contrast, different warnings of contraception have been given to female and male another in Europe for 1 month and 6 months after administration, and in the United States for 6 months and for 3 months. The description of the contraceptive period in the package insert in Japan needs to be described after clearly stating the specific period, and it is necessary to describe detailed information including the contraceptive method in materials such as interview forms.

Published
2021

18. [Retrospective analysis of antiemetic effect in patients receiving cisplatin].

Author

Yonemura M, Akita T, Suzuki S, Gotoh K, Tahara M, Ohtsu A, Ohe Y, Mouri K, and Izumi K

Subjects
Antiemetics administration & dosage, Antineoplastic Agents therapeutic use, Aprepitant, Cisplatin therapeutic use, Female, Humans, Male, Middle Aged, Morpholines administration & dosage, Nausea prevention & control, Retrospective Studies, Antiemetics therapeutic use, Antineoplastic Agents adverse effects, Cisplatin adverse effects, Morpholines therapeutic use, Vomiting prevention & control
Abstract

We retrospectively examined the results of antiemetic therapy with granisetron and dexamethasone; with granisetron, dexamethasone and aprepitant; and with palonosetron, dexamethasone and aprepitant, in patients who received chemotherapy with cisplatin at 50 mg/m2 or more for the first time. Vomiting was dramatically reduced by the concomitant administration of aprepitant. There was no difference in this effect when palonosetron was used instead of granisetron as a serotonin receptor antagonist. There was also no significant difference in the percentage of patients without nausea among the 3 groups. The results of this study indicate that vomiting in patients receiving chemotherapy can be controlled using aprepitant in combination with two other drugs.

Published
2011

Catalog

Books, media, physical & digital resources
See catalog results